According to the Guoxin Securities Research Report, in the fourth quarter of 2024, the steady healthcare (300888.SZ) consumer goods business is expected to grow at an accelerated pace against the backdrop of strong marketing combined with hot events in the industry. Third-party online data shows that from October to November 2024, the total sales growth rate of the Cotton Era brand and Princess Ness brand accelerated significantly compared to the first three quarters of 2024. The sales growth rate of the company's two core categories, cotton towels and sanitary napkins, both increased by more than 30% in October-November; in the medical sector, the impact of the high base of epidemic prevention products was basically eliminated in the third quarter and returned to normal growth; the acquisition of GRI in terms of epitaxial growth is conducive to overseas production capacity and channel development. Based on the increase in profit forecasts, the target price was raised to 43-47 yuan (previous value was 34-36 yuan), corresponding to 24-26 xPE in 2025, maintaining the “superior to market” rating.